Main study | Novel Therapies to Treat Resistant Focal Segmental Glomerulosclerosis: Phase II Clinical Trial |
---|---|
Contact name | Howard Trachtman, MD |
Contact phone | 718-470-3423 |
Contact email | trachtma@lij.edu |
Dua signed dt | March 13, 2009, midnight |
Site approved dt | Feb. 27, 2009, midnight |
Niddk signed dt | March 24, 2009, midnight |